BIIB : Biogen stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-01-16 |
|---|---|---|---|---|
| 2025 | $213.34 | $137.46 | $296.82 | 51.06% |
| 2026 | $341.73 | $306.01 | $367.4 | 141.97% |
| 2027 | $182.57 | $127.16 | $302.43 | 29.27% |
| 2028 | $313.55 | $165.93 | $461.98 | 122.01% |
| 2029 | $436.25 | $374.73 | $471.1 | 208.89% |
| 2030 | $251.27 | $203.36 | $343.71 | 77.91% |
| 2031 | $574.3 | $314.3 | $801.73 | 306.64% |
| 2032 | $839.98 | $814.21 | $857.63 | 494.76% |
| 2033 | $724.13 | $555.21 | $818.1 | 412.73% |
| 2034 | $602.42 | $530.82 | $742.07 | 326.55% |
| 2035 | $796.36 | $796.36 | $796.36 | 463.88% |
The 38 Wall Street analysts offering Biogen stock forecast in the last 6 months have average price target of
$242.0 with a high forecast of $302.0 and a low forecast of $138.0.
The average Biogen stock forecast represents a 71.35%
increase from the last price of $141.229995727539.
For Biogen stock forecast for 2025, 11 predictions are offered for each month of 2025 with average Biogen stock
forecast of $213.34, a high forecast of $296.82, and a low forecast of $137.46.
The average Biogen stock forecast 2025 represents a 51.06%
increase from the last price of $141.229995727539.
For Biogen stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Biogen stock
forecast of $341.73, a high forecast of $367.4, and a low forecast of $306.01.
The average Biogen stock forecast 2026 represents a 141.97%
increase from the last price of $141.229995727539.
For Biogen stock forecast for 2028, 12 predictions are offered for each month of 2028 with average Biogen stock
forecast of $313.55, a high forecast of $461.98, and a low forecast of $165.93.
The average Biogen stock forecast 2028 represents a 122.01%
increase from the last price of $141.229995727539.
For Biogen stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average Biogen stock
forecast of $251.27, a high forecast of $343.71, and a low forecast of $203.36.
The average Biogen stock forecast 2030 represents a 77.91%
increase from the last price of $141.229995727539.
For Biogen stock forecast 2031, 12 predictions are offered for each month of 2031 with average Biogen stock
forecast of $574.3, a high forecast of $801.73, and a low forecast of $314.3.
The average Biogen stock forecast 2031 represents a 306.64%
increase from the last price of $141.229995727539.
For Biogen stock forecast for 2035 (10 year), 1 predictions are offered for each month of 2035 with average Biogen stock
forecast of $796.36, a high forecast of $796.36, and a low forecast of $796.36.
The average Biogen stock forecast 2035 represents a 463.88%
increase from the last price of $141.229995727539.
Please, see more forecasts below.
BIIB : Biogen stock forecast by Wall Street Analysts
The average Biogen stock forecast from last 6 month is $242.0, and this show a -8.59% decrease in average from the prior price target of the each prediction. Also, this average forecast of $242.0 represents a -16.41% decrease from the past average forecast of $289.5, 6 months ago from 40 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-01-10 | Wells Fargo | $190.0000 | $165.0000 | Equal-Weight |
| 2025-01-08 | Truist Securities | $302.00 | $220 | Buy |
| 2025-01-02 | Piper Sandler | $315.0000 | $138 | Neutral |
| 2024-12-20 | BMO Capital | $230.00 | $164 | Market Perform |
| 2024-12-10 | B of A Securities | $178.0000 | Neutral | |
| 2024-12-09 | Jefferies | $250.0000 | $180.0000 | Hold |
| 2024-11-21 | Mizuho | $251.00 | $207 | Outperform |
| 2024-11-18 | Needham | $270.00 | $270.00 | Hold |
| 2024-11-15 | Baird | $294.00 | $300 | Outperform |
| 2024-11-15 | Wolfe Research | Peer Perform | ||
| 2024-11-14 | Citigroup | $190.0000 | Neutral | |
| 2024-11-04 | JP Morgan | $220.0000 | $210.0000 | Neutral |
| 2024-10-31 | Morgan Stanley | $285.0000 | $204 | Equal-Weight |
| 2024-10-31 | Needham | $270.00 | $270.00 | Buy |
| 2024-10-31 | HC Wainwright & Co. | $300.00 | $300.00 | Buy |
| 2024-10-31 | TD Cowen | $300.0000 | $275.0000 | Buy |
| 2024-10-31 | Barclays | $190.00 | $180.0000 | Equal-Weight |
| 2024-10-31 | Oppenheimer | $270.00 | $255 | Outperform |
| 2024-10-30 | Needham | $270.0000 | $270 | Buy |
| 2024-10-17 | BMO Capital | $260.0000 | $230 | Outperform |
| 2024-10-10 | Raymond James | Market Perform | ||
| 2024-10-04 | RBC Capital | $292.00 | $269.0000 | Outperform |
| 2024-10-03 | UBS | $234.0000 | $202.0000 | Neutral |
| 2024-09-24 | Needham | $285.00 | $285.00 | Buy |
| 2024-09-23 | Wedbush | $210.00 | $205.0000 | Neutral |
| 2024-09-19 | RBC Capital | $292.00 | $292.00 | Outperform |
| 2024-09-09 | Cantor Fitzgerald | $292.0000 | $292 | Overweight |
| 2024-09-04 | Needham | $285.00 | $285.00 | Buy |
| 2024-08-19 | Needham | $285.00 | $285.00 | Buy |
| 2024-08-06 | Mizuho | $277.00 | $251 | Outperform |
| 2024-08-05 | Needham | $288.00 | $285.00 | Buy |
| 2024-08-05 | Truist Securities | $340.00 | $302.0000 | Buy |
| 2024-08-02 | Wedbush | $215.00 | $210 | Neutral |
| 2024-08-02 | Barclays | $200.00 | $190.0000 | Equal-Weight |
| 2024-08-02 | Scotiabank | $275.0000 | $244.0000 | Sector Outperform |
| 2024-08-02 | Wells Fargo | $240.00 | $225.0000 | Equal-Weight |
| 2024-08-02 | RBC Capital | $282.0000 | $292 | Outperform |
| 2024-08-01 | Needham | $288.0000 | $288 | Buy |
| 2024-07-29 | Baird | $316.00 | $294 | Outperform |
| 2024-07-26 | Needham | $294.00 | $294.00 | Buy |
| 2024-07-12 | Piper Sandler | $335.0000 | $313 | Overweight |
| 2024-06-28 | Needham | $294.00 | $294.00 | Buy |
| 2024-06-27 | RBC Capital | $317.00 | $317.00 | Outperform |
| 2024-06-26 | RBC Capital | $317.00 | $317.00 | Outperform |
| 2024-06-05 | RBC Capital | $317.00 | $317.00 | Outperform |
| 2024-05-29 | RBC Capital | $317 | Outperform | |
| 2024-05-23 | HC Wainwright & Co. | $300.0000 | Buy | |
| 2024-05-22 | Needham | $294.0000 | Buy | |
| 2024-05-16 | Truist Securities | $340.00 | $340 | Buy |
| 2024-05-03 | HSBC | $339.0000 | $342.0000 | Buy |
| 2024-04-29 | Oppenheimer | $270.00 | $270 | Outperform |
| 2024-04-25 | Needham | $294.00 | Buy | |
| 2024-04-25 | HC Wainwright & Co. | $325.00 | $300.0000 | Buy |
| 2024-04-25 | Wedbush | $213.0000 | $215 | Neutral |
| 2024-04-25 | Barclays | $215.00 | $200.0000 | Equal-Weight |
| 2024-04-24 | Needham | $294.00 | Buy | |
| 2024-04-19 | Oppenheimer | $290.00 | $270 | Outperform |
| 2024-04-17 | UBS | $250.00 | $214.0000 | Neutral |
| 2024-04-17 | Wedbush | $245.0000 | $213.0000 | Neutral |
| 2024-04-12 | B of A Securities | $280.0000 | $260 | Neutral |
| 2024-04-11 | JP Morgan | $270.0000 | $240.0000 | Neutral |
| 2024-04-04 | Barclays | $230.0000 | $215.0000 | Equal-Weight |
| 2024-03-25 | Truist Securities | $340.0000 | Buy | |
| 2024-03-05 | RBC Capital | $364.0000 | Outperform | |
| 2024-02-22 | Mizuho | $355.0000 | $277 | Buy |
| 2024-02-20 | Canaccord Genuity | $310.0000 | $305.0000 | Buy |
| 2024-02-20 | Cantor Fitzgerald | $311.0000 | Overweight | |
| 2024-02-16 | UBS | $276.00 | $250 | Neutral |
| 2024-02-14 | HC Wainwright & Co. | $325.0000 | Buy | |
| 2024-02-14 | Baird | $333.0000 | $316 | Outperform |
| 2024-02-14 | Piper Sandler | $350.0000 | $325 | Overweight |
| 2024-02-14 | BMO Capital | $295.0000 | $285 | Outperform |
| 2024-02-14 | Oppenheimer | $295.00 | $290 | Outperform |
| 2024-02-14 | RBC Capital | $379.0000 | $364 | Outperform |
| 2024-02-14 | Wells Fargo | $315 | $240.0000 | Equal-Weight |
| 2024-02-14 | Needham | $305.00 | $300.0000 | Buy |
| 2024-02-13 | Needham | $305.0000 | Buy | |
| 2024-01-30 | Oppenheimer | $295.0000 | Outperform | |
| 2024-01-25 | UBS | $311.0000 | $276.0000 | Neutral |
| 2024-01-24 | UBS | $276.0000 | Neutral |
Biogen stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-01-20 | $135.05 | -4.37% |
| 2025-01-21 | $137.64 | 1.91% |
| 2025-01-22 | $137.56 | -0.06% |
| 2025-01-23 | $133.82 | -2.71% |
| 2025-01-24 | $132.03 | -1.34% |
BIIB : Long term Biogen stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 Feb. is $137.46 , for 2026 Jan. is $306.01 , for 2029 Jan. is $470.13 , for 2030 Jan. is $343.71 , for 2034 Jan. is $537.79 , and for 2035 Jan. is $796.36.
BIIB : Biogen stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Feb. | $137.46 | -2.67% |
| 2025 Mar. | $141.86 | 3.20% |
| 2025 Apr. | $154.97 | 9.24% |
| 2025 May. | $173.10 | 11.70% |
| 2025 Jun. | $193.21 | 11.62% |
| 2025 Jul. | $213.41 | 10.46% |
| 2025 Aug. | $232.67 | 9.02% |
| 2025 Sep. | $250.97 | 7.87% |
| 2025 Oct. | $268.26 | 6.89% |
| 2025 Nov. | $284.02 | 5.88% |
| 2025 Dec. | $296.82 | 4.51% |
BIIB : Biogen stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $306.01 | 3.10% |
| 2026 Feb. | $314.73 | 2.85% |
| 2026 Mar. | $324.03 | 2.95% |
| 2026 Apr. | $334.41 | 3.20% |
| 2026 May. | $345.54 | 3.33% |
| 2026 Jun. | $356.32 | 3.12% |
| 2026 Jul. | $364.38 | 2.26% |
| 2026 Aug. | $367.40 | 0.83% |
| 2026 Sep. | $364.36 | -0.83% |
| 2026 Oct. | $355.67 | -2.38% |
| 2026 Nov. | $342.49 | -3.71% |
| 2026 Dec. | $325.47 | -4.97% |
BIIB : Biogen stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $302.43 | -7.08% |
| 2027 Feb. | $273.84 | -9.45% |
| 2027 Mar. | $242.84 | -11.32% |
| 2027 Apr. | $212.25 | -12.60% |
| 2027 May. | $183.91 | -13.35% |
| 2027 Jun. | $159.97 | -13.02% |
| 2027 Jul. | $142.32 | -11.04% |
| 2027 Aug. | $131.51 | -7.60% |
| 2027 Sep. | $127.16 | -3.30% |
| 2027 Oct. | $128.99 | 1.44% |
| 2027 Nov. | $136.49 | 5.81% |
| 2027 Dec. | $149.15 | 9.27% |
BIIB : Biogen stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $165.93 | 11.26% |
| 2028 Feb. | $186.30 | 12.27% |
| 2028 Mar. | $209.67 | 12.55% |
| 2028 Apr. | $234.90 | 12.03% |
| 2028 May. | $261.71 | 11.41% |
| 2028 Jun. | $290.67 | 11.07% |
| 2028 Jul. | $323.24 | 11.20% |
| 2028 Aug. | $359.62 | 11.25% |
| 2028 Sep. | $395.66 | 10.02% |
| 2028 Oct. | $425.46 | 7.53% |
| 2028 Nov. | $447.41 | 5.16% |
| 2028 Dec. | $461.98 | 3.26% |
BIIB : Biogen stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $470.13 | 1.76% |
| 2029 Feb. | $471.10 | 0.21% |
| 2029 Mar. | $466.79 | -0.92% |
| 2029 Apr. | $459.56 | -1.55% |
| 2029 May. | $451.37 | -1.78% |
| 2029 Jun. | $443.45 | -1.75% |
| 2029 Jul. | $436.22 | -1.63% |
| 2029 Aug. | $429.31 | -1.58% |
| 2029 Sep. | $422.02 | -1.70% |
| 2029 Oct. | $412.67 | -2.22% |
| 2029 Nov. | $397.65 | -3.64% |
| 2029 Dec. | $374.73 | -5.77% |
BIIB : Biogen stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $343.71 | -8.28% |
| 2030 Feb. | $307.43 | -10.55% |
| 2030 Mar. | $272.03 | -11.52% |
| 2030 Apr. | $241.61 | -11.18% |
| 2030 May. | $219.16 | -9.29% |
| 2030 Jun. | $206.52 | -5.77% |
| 2030 Jul. | $203.36 | -1.53% |
| 2030 Aug. | $208.63 | 2.59% |
| 2030 Sep. | $221.45 | 6.14% |
| 2030 Oct. | $240.42 | 8.57% |
| 2030 Nov. | $263.16 | 9.46% |
| 2030 Dec. | $287.74 | 9.34% |
BIIB : Biogen stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $314.30 | 9.23% |
| 2031 Feb. | $345.18 | 9.82% |
| 2031 Mar. | $383.08 | 10.98% |
| 2031 Apr. | $431.51 | 12.64% |
| 2031 May. | $493.34 | 14.33% |
| 2031 Jun. | $560.19 | 13.55% |
| 2031 Jul. | $622.04 | 11.04% |
| 2031 Aug. | $676.69 | 8.79% |
| 2031 Sep. | $722.43 | 6.76% |
| 2031 Oct. | $757.68 | 4.88% |
| 2031 Nov. | $783.44 | 3.40% |
| 2031 Dec. | $801.73 | 2.34% |
BIIB : Biogen stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $814.21 | 1.56% |
| 2032 Feb. | $822.35 | 1.00% |
| 2032 Mar. | $827.68 | 0.65% |
| 2032 Apr. | $832.93 | 0.63% |
| 2032 May. | $838.79 | 0.70% |
| 2032 Jun. | $844.60 | 0.69% |
| 2032 Jul. | $850.44 | 0.69% |
| 2032 Aug. | $855.25 | 0.57% |
| 2032 Sep. | $857.63 | 0.28% |
| 2032 Oct. | $855.45 | -0.25% |
| 2032 Nov. | $846.97 | -0.99% |
| 2032 Dec. | $833.45 | -1.60% |
BIIB : Biogen stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $818.10 | -1.84% |
| 2033 Feb. | $801.63 | -2.01% |
| 2033 Mar. | $784.29 | -2.16% |
| 2033 Apr. | $765.73 | -2.37% |
| 2033 May. | $749.31 | -2.14% |
| 2033 Jun. | $744.83 | -0.60% |
| 2033 Jul. | $753.99 | 1.23% |
| 2033 Aug. | $757.40 | 0.45% |
| 2033 Sep. | $734.65 | -3.00% |
| 2033 Oct. | $637.06 | -13.28% |
| 2033 Nov. | $587.32 | -7.81% |
| 2033 Dec. | $555.21 | -5.47% |
BIIB : Biogen stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $537.79 | -3.14% |
| 2034 Feb. | $530.82 | -1.30% |
| 2034 Mar. | $533.85 | 0.57% |
| 2034 Apr. | $547.47 | 2.55% |
| 2034 May. | $566.09 | 3.40% |
| 2034 Jun. | $583.82 | 3.13% |
| 2034 Jul. | $599.31 | 2.65% |
| 2034 Aug. | $613.39 | 2.35% |
| 2034 Sep. | $625.88 | 2.04% |
| 2034 Oct. | $654.76 | 4.61% |
| 2034 Nov. | $693.76 | 5.96% |
| 2034 Dec. | $742.07 | 6.96% |
BIIB : Biogen stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $796.36 | 7.32% |
Frequently Asked Questions about Biogen stock forecast
Is Biogen a good long term stock?
From Biogen stock forecast , Biogen (BIIB) stock cannot be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2025 Feb. is $137.456167692248 From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2026 Jan. is $306.008877273093 From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2029 Jan. is $470.12887863119 From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2030 Jan. is $343.708454447135 From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2034 Jan. is $537.788567073841 From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2035 Jan. is $796.362311626537
Is Biogen stock overvalued?
Biogen (BIIB) stock is expected to go UP . Therefore, AIPickup would say that Biogen (BIIB) stock is NOT overvalued.
Will Biogen stock price go up?
Yes. The Biogen stock price forecast for 2026 Jan. is $306.008877273093
Is Biogen stock a good buy now?
Since closing price on 2025-01-16 is $141.229995727539 and forecast for 2026 Jan. is $306.01, Biogen stock is a good 1 year investment.
14 Days Historical Data for Biogen stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| BIIB stock price for 2024-12-26 | $149.90 | $148.00 | $147.83 | $150.68 |
| BIIB stock price for 2024-12-27 | $151.31 | $148.74 | $148.23 | $151.88 |
| BIIB stock price for 2024-12-30 | $150.19 | $150.92 | $148.19 | $151.18 |
| BIIB stock price for 2024-12-31 | $152.92 | $150.80 | $150.19 | $153.04 |
| BIIB stock price for 2025-01-02 | $150.00 | $153.84 | $149.84 | $154.12 |
| BIIB stock price for 2025-01-03 | $152.21 | $149.73 | $149.73 | $152.97 |
| BIIB stock price for 2025-01-06 | $153.27 | $151.93 | $151.62 | $153.60 |
| BIIB stock price for 2025-01-07 | $153.15 | $153.11 | $152.90 | $156.37 |
| BIIB stock price for 2025-01-08 | $150.75 | $152.27 | $150.07 | $152.82 |
| BIIB stock price for 2025-01-10 | $148.82 | $149.18 | $147.65 | $150.20 |
| BIIB stock price for 2025-01-13 | $150.18 | $148.92 | $145.82 | $150.48 |
| BIIB stock price for 2025-01-14 | $143.06 | $149.92 | $142.42 | $150.22 |
| BIIB stock price for 2025-01-15 | $141.00 | $145.46 | $140.87 | $146.15 |
| BIIB stock price for 2025-01-16 | $141.23 | $140.49 | $140.05 | $142.39 |